Inapplicable
Inapplicable is an intervention with 6 clinical trials. Currently 2 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 2 completed trials
Phase Distribution
No phase data available
Trial Status & Enrollment
100.0%
2 of 2 finished
0.0%
0 ended early
2
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Status
Recent Activity
AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients
Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks
Study on the Correlation Between Metabolomics and Anxiety and Depression in Bronchiectasis
Study on Disease Progression and Nutritional Status in Bronchiectasis
Clinical Trials (6)
AI-based Model for Rehabilitation Engagement and Motor Performance Evaluation in Pediatric Patients
Observational Study to Observe Variations of Gait Parameters in Patients With Neuromuscular Diseases
A Study Observing US Patients With HAE Type I or II Who Take Icatibant to Treat HAE Attacks
Study on the Correlation Between Metabolomics and Anxiety and Depression in Bronchiectasis
Study on Disease Progression and Nutritional Status in Bronchiectasis
Exploring the Effectiveness and Factors Affecting the Collection of Single Nucleated Cells From Different Volunteers
All 6 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 6